Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Davidson

Showing results (281-290 of 358) with videos related to

Pageof 36
Sort By:
American Journal of Obstetrics and Gynecology|October 23, 2010
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesisIe-Ming Shih, Li Chen, Chen C Wang, et al.
BMC Cancer|February 12, 2014
Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic markerBente Vilming Elgaaen, Ole Kristoffer Olstad, Kari Bente Foss Haug, et al.
Cancer Research|January 25, 2005
Apolipoprotein E is required for cell proliferation and survival in ovarian cancerYu-Chi Chen, Gudrun Pohl, Tian-Li Wang, et al.
Virchows Archiv : an International Journal of Pathology|March 17, 2006
Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinomaLilach Kleinberg, Vivi Ann Flørenes, Martina Skrede, et al.
Human Pathology|April 12, 2016
MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinomaDag Andre Nymoen, Ana Slipicevic, Arild Holth, et al.
Journal of Translational Medicine|July 9, 2024
Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancerChristin Lund-Andersen, Annette Torgunrud, Chakravarthi Kanduri, et al.
Cancer|June 22, 2010
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancerChristina M Annunziata, Helene Tuft Stavnes, Lilach Kleinberg, et al.
Plos One|June 19, 2008
MicroRNA expression and identification of putative miRNA targets in ovarian cancerNeetu Dahiya, Cheryl A Sherman-Baust, Tian-Li Wang, et al.
Human Pathology|February 4, 2014
Gene expression signatures of primary and metastatic uterine leiomyosarcomaBen Davidson, Vera Maria Abeler, Mette Førsund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profilingBen Davidson, Virginia Espina, Seth M Steinberg, et al.
Pageof 36

Showing results (281-290 of 358) with videos related to

Sort By:
Pageof 36
American Journal of Obstetrics and Gynecology|October 23, 2010
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesisIe-Ming Shih, Li Chen, Chen C Wang, et al.
BMC Cancer|February 12, 2014
Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic markerBente Vilming Elgaaen, Ole Kristoffer Olstad, Kari Bente Foss Haug, et al.
Cancer Research|January 25, 2005
Apolipoprotein E is required for cell proliferation and survival in ovarian cancerYu-Chi Chen, Gudrun Pohl, Tian-Li Wang, et al.
Virchows Archiv : an International Journal of Pathology|March 17, 2006
Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinomaLilach Kleinberg, Vivi Ann Flørenes, Martina Skrede, et al.
Human Pathology|April 12, 2016
MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinomaDag Andre Nymoen, Ana Slipicevic, Arild Holth, et al.
Journal of Translational Medicine|July 9, 2024
Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancerChristin Lund-Andersen, Annette Torgunrud, Chakravarthi Kanduri, et al.
Cancer|June 22, 2010
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancerChristina M Annunziata, Helene Tuft Stavnes, Lilach Kleinberg, et al.
Plos One|June 19, 2008
MicroRNA expression and identification of putative miRNA targets in ovarian cancerNeetu Dahiya, Cheryl A Sherman-Baust, Tian-Li Wang, et al.
Human Pathology|February 4, 2014
Gene expression signatures of primary and metastatic uterine leiomyosarcomaBen Davidson, Vera Maria Abeler, Mette Førsund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profilingBen Davidson, Virginia Espina, Seth M Steinberg, et al.
Pageof 36